JP2021520353A5 - - Google Patents
Info
- Publication number
- JP2021520353A5 JP2021520353A5 JP2020554078A JP2020554078A JP2021520353A5 JP 2021520353 A5 JP2021520353 A5 JP 2021520353A5 JP 2020554078 A JP2020554078 A JP 2020554078A JP 2020554078 A JP2020554078 A JP 2020554078A JP 2021520353 A5 JP2021520353 A5 JP 2021520353A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- formulated
- composition according
- administration
- months
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862652818P | 2018-04-04 | 2018-04-04 | |
| US62/652,818 | 2018-04-04 | ||
| PCT/US2019/025796 WO2019195554A1 (en) | 2018-04-04 | 2019-04-04 | Methods of treating cerebral palsy and hypoxic-ischemic encephalopathy using human umbilical cord tissue-derived mesenchymal stromal cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021520353A JP2021520353A (ja) | 2021-08-19 |
| JPWO2019195554A5 JPWO2019195554A5 (https=) | 2022-04-11 |
| JP2021520353A5 true JP2021520353A5 (https=) | 2022-04-11 |
Family
ID=68101217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554078A Pending JP2021520353A (ja) | 2018-04-04 | 2019-04-04 | ヒト臍帯組織由来の間葉系間質細胞を使用して脳性麻痺および低酸素性虚血性脳症を処置する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210361716A1 (https=) |
| EP (1) | EP3773624A4 (https=) |
| JP (1) | JP2021520353A (https=) |
| KR (1) | KR20210021946A (https=) |
| CN (1) | CN112236152A (https=) |
| AU (1) | AU2019247383B2 (https=) |
| BR (1) | BR112020020288A2 (https=) |
| CA (1) | CA3096037A1 (https=) |
| IL (1) | IL277732A (https=) |
| SG (1) | SG11202009800SA (https=) |
| WO (1) | WO2019195554A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024075676A1 (ja) * | 2022-10-03 | 2024-04-11 | キッズウェル・バイオ株式会社 | 脳性まひの予防又は治療剤 |
| WO2025100424A1 (ja) * | 2023-11-10 | 2025-05-15 | 国立大学法人 東京大学 | 急性脳症治療剤及び急性脳症の治療方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1803193A (zh) * | 2005-01-13 | 2006-07-19 | 中山大学 | 骨髓来源的间质干细胞用于制备治疗缺氧缺血性脑性瘫痪的制剂的用途 |
| US20070128722A1 (en) * | 2005-12-05 | 2007-06-07 | Industrial Technology Research Institute | Human mesenchymal stem cells and culturing methods thereof |
| US20170042944A1 (en) * | 2014-04-21 | 2017-02-16 | Anthrogenesis Corporation | Treatment of conditions and complications in infants |
| WO2016019332A1 (en) * | 2014-07-29 | 2016-02-04 | Ingeneron, Inc. | Method and apparatus for recovery of umbilical cord tissue derived regenerative cells and uses thereof |
| WO2017144552A1 (en) * | 2016-02-22 | 2017-08-31 | Centauri Biotech. S.L. | Pharmaceutical or veterinary cell compositions comprising mesenchymal stromal cells (mscs) and dimethyl sulfoxide (dmso) |
| JP7126703B2 (ja) * | 2016-05-24 | 2022-08-29 | 国立大学法人 東京大学 | 臍帯由来細胞を含む脳障害の治療剤 |
| KR101973284B1 (ko) * | 2017-01-16 | 2019-04-29 | 사회복지법인 삼성생명공익재단 | 신생아 ｈｉｅ 치료용 조성물 |
-
2019
- 2019-04-04 JP JP2020554078A patent/JP2021520353A/ja active Pending
- 2019-04-04 AU AU2019247383A patent/AU2019247383B2/en active Active
- 2019-04-04 BR BR112020020288-6A patent/BR112020020288A2/pt unknown
- 2019-04-04 EP EP19782175.4A patent/EP3773624A4/en active Pending
- 2019-04-04 US US17/044,744 patent/US20210361716A1/en not_active Abandoned
- 2019-04-04 WO PCT/US2019/025796 patent/WO2019195554A1/en not_active Ceased
- 2019-04-04 CA CA3096037A patent/CA3096037A1/en active Pending
- 2019-04-04 KR KR1020207031726A patent/KR20210021946A/ko not_active Ceased
- 2019-04-04 SG SG11202009800SA patent/SG11202009800SA/en unknown
- 2019-04-04 CN CN201980032411.XA patent/CN112236152A/zh active Pending
-
2020
- 2020-10-01 IL IL277732A patent/IL277732A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chen et al. | Thalidomide combined with low-dose glucocorticoid in the treatment of COVID-19 pneumonia | |
| ES2666657T3 (es) | Fenfluramina para uso en el tratamiento de síndrome de Dravet | |
| JP2020033360A5 (https=) | ||
| ES2180809T5 (es) | Administracion de selegilina sublingual y bucal. | |
| Yoon et al. | Complete Remission of Hypereosinophilic Syndrome after Interferon‐α Therapy: Report of a Case and Literature Review | |
| JP2021520353A5 (https=) | ||
| WO2021050583A1 (en) | Treatment of traumatic encephalopathy by fibroblasts and therapeutic adjuvants | |
| CN1329032C (zh) | 非镇静巴比土酸盐化合物用作神经保护剂 | |
| Tyndall et al. | High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction | |
| CN107582566A (zh) | 通过多胺化合物调控自身免疫性疾病的方法和组合物 | |
| CN110719778A (zh) | 用于治疗抑郁的组合物和方法 | |
| TW202106690A (zh) | 皮膚型紅斑狼瘡之治療 | |
| JPWO2019195554A5 (https=) | ||
| BR0114642A (pt) | Prevenção de doenças através da reativação do timo | |
| WO2022007832A1 (zh) | 组合物在治疗脑卒中的用途 | |
| Ford | Heat stroke with mepazine therapy | |
| Tomioka et al. | In vivo antileprosy activity of the newly synthesized benzoxazinorifamycin, KRM-1648 | |
| McQueen et al. | Pre-labour rupture of membranes with an unripe cervix: a random trial of management | |
| O'LEARY et al. | Hyaluronidase as an adjuvant to episiotomy | |
| Shukla et al. | Section: Anesthesiology | |
| Lauersen et al. | Midtrimester abortion induced by serial intramuscular injections of 15 (S)-15-methyl-prostaglandin E2 methyl ester | |
| WO2022007833A1 (zh) | 一种组合物在治疗脑卒中的用途 | |
| Eccleston Jr et al. | A Preliminary Report on the Combination of the Hypothermic and Hypotensive Techniques. | |
| Janssens et al. | Tinidazole in the prevention of post-operative wound infection after hysterectomy | |
| Sleath et al. | Clinical evaluation of a new triple penicillin salt in the treatment of acute gonorrhoea |